318 Results

People

  1. Motzer
    Motzer
  2. Rosenberg
    Rosenberg
  3. Hellmann
    Hellmann
  4. Rudin
    Rudin
  5. Schoenfeld
    Schoenfeld
  6. Iyer
    Iyer
  7. Ladanyi
    Ladanyi
  8. Wolchok
    Wolchok
  9. O'Cearbhaill
    O'Cearbhaill
  10. Rizvi
    Rizvi

Groups

  1. Department of Medicine (217)
  2. Solid Tumor Oncology Division (188)
  3. GSK Faculty (66)
  4. Hematologic Malignancies, Division of (65)
  5. Genitourinary Oncology Service (60)
  6. Department of Pathology and Laboratory Medicine (59)
  7. Sloan Kettering Institute Postdocs (52)
  8. Surgery (49)
  9. Thoracic Oncology (46)
  10. Weinberg Fellows (41)
  1. "programmed death 1 ligand 1"
Formats
  1. Journal Article (231)
  2. Review (46)
  3. Editorial (21)
  4. Correspondence (6)
  5. Guidelines (6)
  6. Research Letter (6)
  7. Miscellaneous (2)
Groups
  1. Department of Medicine (217)
  2. Solid Tumor Oncology Division (188)
  3. GSK Faculty (66)
  4. Hematologic Malignancies, Division of (65)
  5. Genitourinary Oncology Service (60)
  6. Department of Pathology and Laboratory Medicine (59)

More Groups

People
  1. Robert Motzer (20)
  2. Jonathan Rosenberg (16)
  3. Jedd Wolchok (15)
  4. Matthew Hellmann (14)
  5. Adam Schoenfeld (10)
  6. Charles Rudin (10)

More People

Years
  1. 2025 (25)
  2. 2024 (53)
  3. 2023 (44)
  4. 2022 (49)
  5. 2021 (29)
  6. 2020 (43)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (19)
  2. Clinical Cancer Research (17)
  3. Annals of Oncology (15)
  4. Journal of Clinical Oncology (14)
  5. Journal of Thoracic Oncology (8)
  6. New England Journal of Medicine (8)

More Publications

Publishers
  1. Elsevier Inc. (44)
  2. Nature Publishing Group (26)
  3. American Association for Cancer Research (24)
  4. Biomed Central Ltd (21)
  5. Oxford University Press (18)
  6. Elsevier Science, Inc. (17)

More Publishers

Results (318)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of C-reactive protein in predicting the severity and response of immune-mediated diarrhea and colitis in patients with cancer
    Journal Article

    Liu, C.; Shatila, M.; Mathew, A.; Machado, A. P.; Thomas, A.; Zhang, H. C.; Thomas, A. S.; Faleck, D.; Funchain, P.; Philpott, J.; more...
    Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
    Journal Article

    Raj, N.; Chan, J. A.; Wang, S. J.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Fong, L.; Grabowsky, J.; Hope, T. A.; Kolli, K. P.; more...
    British Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC
    Journal Article

    Alessi, J. V.; Ricciuti, B.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; Elkrief, A.; Rodig, S. J.; Lebow, E. S.; Eicholz, J. E.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Long-term outcomes and molecular correlates of sotorasib efficacy in patients with pretreated KRAS G12C-mutated non-small-cell lung cancer: 2-Year analysis of CodeBreaK 100
    Journal Article

    Dy, G. K.; Govindan, R.; Velcheti, V.; Falchook, G. S.; Italiano, A.; Wolf, J.; Sacher, A. G.; Takahashi, T.; Ramalingam, S. S.; Dooms, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
    Guidelines

    Disis, M. L.; Adams, S. F.; Bajpai, J.; Butler, M. O.; Curiel, T.; Dodt, S. A.; Doherty, L.; Emens, L. A.; Friedman, C. F.; Gatti-Mays, M.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma
    Journal Article

    Restle, D.; Dux, J.; Li, X.; Byun, A. J.; Choe, J. K.; Li, Y.; Vaghjiani, R. G.; Thomas, C.; Misawa, K.; Tan, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
    Journal Article

    Ho, P.; Melms, J. C.; Rogava, M.; Frangieh, C. J.; Poźniak, J.; Shah, S. B.; Walsh, Z.; Kyrysyuk, O.; Amin, A. D.; Caprio, L.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
    Journal Article

    Nabbi, A.; Danesh, A.; Espin-Garcia, O.; Pedersen, S.; Wellum, J.; Fu, L. H.; Paulson, J. N.; Geoerger, B.; Marshall, L. V.; Trippett, T.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Risk of diabetes mellitus among users of immune checkpoint inhibitors: A population-based cohort study
    Journal Article

    Chan, J. S. K.; Lee, S.; Kong, D.; Lakhani, I.; Ng, K.; Dee, E. C.; Tang, P.; Lee, Y. H. A.; Satti, D. I.; Wong, W. T.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save